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Abstract The cysteine-rich region (CRR) of the integrin L
subunits is organised into four repeating elements. By expression
of a panel of truncated L2 subunits, and CRR segments fused to
the C-terminal end of a CD4 soluble fragment, the segment
required for the expression of two monoclonal antibody
conformational epitopes was determined. This segment, E482^
Q574, contains 16 cysteines representing two repeating units. We
have thus defined the CRR unit motif of ‘xCöCöCö
CxCxxCxCöCx’, where ‘x’ represents a single residue, and
‘ö’ represents a stretch of four to 14 residues. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
The integrins are a family of cell adhesion molecules that
mediate a wide repertoire of biological functions [1]. The in-
tegrins are obligate heterodimers, each composed of an K sub-
unit and a L subunit. Both the K and L subunits are type I
membrane proteins with relatively large extracellular domains
(V700^1000 residues). Analyses of the primary structure of
the K subunits showed seven repeating elements each of about
60 residues at the N-terminal. They have been predicted to
assume the fold of a L propeller [2]. Nine of the 18 K subunits
have an I-domain inserted between the second and third blade
of the proposed L-propeller structure. The I-domains of the
K2, KL, and KM subunits have been crystallised and shown to
have a dinucleotide binding domain fold. In these integrins,
the I-domains have an important role in binding to ligands [1].
The structure of the remaining extracellular domains of the K
subunits was predicted to form four to six Ig-like domains [3].
The extracellular domains of the L subunits are organised
linearly, from the N-terminal, a plexin^semaphorin^integrin
domain [4], a spacer segment, a highly conserved region which
has been predicted to assume an I-domain-like fold [5,6], a
mid-region, and the major cysteine-rich region (CRR). Per-
haps the most outstanding feature of the L subunit is the
high level of cysteine residues arranged in a very conserved
and characteristic pattern. The CRR has been postulated to
contain three or four repeating elements, each containing
eight cysteine residues [7,8].
The domain organisation of the CRR remains unclear. Pri-
mary structure analyses suggested that each repeating element
in the CRR should contain eight cysteines. However, it is not
possible to determine which sliding segment with eight cys-
teines should constitute a repeating unit. Thus, various assign-
ments have been proposed (for example, see [7^12]). The gene
of the L2 integrin contains 16 exons, with the CRR encoded in
exons 11^14 [13]. However, the size of the exons are irregular,
and the exon boundaries do not provide any information
regarding the postulated repeating structures in the CRR. In
this article, we describe the experiments leading to the deter-
mination of the repeating units. We make use of our earlier
observation that the series of L2 C-terminal truncated variants
can support LFA-1 and Mac-1 expression and function [14].
The shortest of these variants was L2-C445*, in which the
codon for the cysteine residue at position 445 was converted
to a stop codon. Thus, we employ the strategy of constructing
truncated variants of the L2 of increasing length from L2-
C445*. Since the cysteine residues hold the key in de¢ning
the domains in this region, the codons for the cysteine resi-
dues were systematically converted into stop codons. The
cDNA constructs were transfected into COS-7 cells and the
expression of the epitopes of two monoclonal antibodies
(mAbs), KIM127 and MEM-48, was monitored. The epitopes
of these mAbs had been mapped to the CRR of the integrin
L2 subunit [11,12,15^17], and had been shown to be confor-
mational. In particular, they fail to recognise the denatured L2
subunit under reducing conditions by Western blot analyses
[15,16]. The rationale of this strategy is based on the argument
that the expression of each of these epitopes is possible only
when a complete repeating element is included in the con-
struct, and only when the appropriate disulphide bonds are
formed. After the C-terminal ends for the repeating units were
identi¢ed, truncated constructs were made from the N-termi-
nal. They were linked to the C-terminal of a construct encod-
ing the Ig domains 3 and 4 of rat CD4. The fusion proteins
were expressed, and the appearance of the epitopes for the
two mAbs was monitored. The repeating units in the CRR
were thus de¢ned.
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2. Materials and methods
The mAbs MEM-148 [18], KIM127 [15] and MEM-48 [16] were
described previously. MHM24 [19] was a gift from A.J. McMichael
(John Radcli¡e Hospital, Oxford, UK). KB43 [20] was a gift from K.
Pulford (Leukaemia Research Fund Immunodiagnostic Unit, John
Radcli¡e Hospital, Oxford, UK). The mAb OX68 is against the Ig
domains 3 and 4 of rat CD4, and is provided by M. Puklavac (Sir
William Dunn School of Pathology, Oxford, UK). The cDNA con-
struct for Ig domains 3 and 4 of rat CD4 [21] was a gift from M.H.
Brown (Sir William Dunn School of Pathology, Oxford, UK).
The cDNAs of the integrin L2 subunit truncation variants were
constructed with standard molecular biology techniques as previously
described [14]. The cDNA for the CD4 domains was introduced into
pcDNA3.1/Zeo(+) vector (Invitrogen, Groningen, The Netherlands).
L2 Integrin fragments were synthesised by PCR and inserted into the
EcoRI and BamHI sites in the CD4 expression construct [21]. All
constructs were veri¢ed by sequencing (DNA Sequencing Facility,
Department of Biochemistry, University of Oxford, Oxford, UK).
The constructs were transfected into COS-7 cells as previously de-
scribed [14]. To detect intracellular proteins, cells were harvested and
washed once with phosphate-bu¡ered saline (PBS). Cells were ¢xed
with 3.7% paraformaldehyde (w/v) in PBS for 10 min at room temper-
ature. Fixed cells were washed once with PBS and incubated in CSK
bu¡er (100 mM NaCl, 300 mM sucrose, 10 mM PIPES, 3 mM
MgCl2, 1 mM EGTA, pH 6.8) containing 0.25% (v/v) Triton X-100,
0.5 mM phenylmethylsulfonyl £uoride, and 2.5 mM iodoacetamide
for 2 min at room temperature. Permeabilised cells were stained
with the mAbs of interest as described before [14].
Immunoprecipitation of metabolically labelled proteins from tissue
culture supernatants was carried out as previously described [14].
3. Results
3.1. Progressive appearance of mAb epitopes in truncated
L2 variants
Previously, we found that conversion of the codon for C445
into a stop codon [14] results in the expression of the shortest
L2 truncated variant that can support surface expression of a
functionally active LFA-1. In this variant, only the epitopes of
mAb mapped to the mid-region, such as the mAbs H52 and
MEM-148, were expressed. In this work, we introduced stop
codons in the CRR to generate a series of L2 truncation
variants of increasing length (for the L2 CRR sequence, see
Fig. 1). The cDNA of these variants was transfected into
COS-7 cells. Since these variants were not expressed on the
cell surface without an integrin K subunit, we adopted the
strategy of ¢rst ¢xing the cells, and then analysing for expres-
sion of the mAb epitopes in the intracellular pool by £ow
cytometry. The results are shown in Fig. 2A. The epitopes
for KIM127 and MEM-48 appear on L2-C575* and longer
variants, but not on L2-C573* and shorter variants. In addi-
tion, we have constructed the variant L2-D435*, which fails to
express the MEM-148 epitope. The key histograms are shown
in Fig. 2B.
3.2. Expression of discrete CRR domains as fusion proteins
to CD4
The above results demarcate the C-terminal boundary, at
C575 of the L2 subunit, required for the expression of the
Fig. 1. The CRR of the L2 integrin subunit. The numbering on top
of the sequence is that of the L2 subunit with the initiation methio-
nine as ‘1’. The numbering below the sequence only counts the cys-
teines. Based on the experiments described in this article, the four
repeats are shown as CRR1, CRR2, CRR3, and CRR4. The pseu-
do-repeat CRR1 is shown in brackets. Since the pattern of cysteine
residues are very conserved and characteristic, we ¢nd it more con-
venient to refer to the extracellular cysteines C1 to C56 from the
N-terminus [22], particular to those who work on integrin L sub-
units other than the one under study. The numbers are in italics
under the main amino acid sequence.
Fig. 2. The truncated variants of the L2 integrin subunit were trans-
fected into COS-7 cells, and the intracellular expression of the epi-
topes of the mAbs MEM-148, KIM127 and MEM-48 were moni-
tored by £ow cytometry. A summary of the results is shown in (A).
The residues at which stop codons were introduced are given both
as the residue on the L2 sequence and, in the cases where the resi-
dues are cysteines, the numbering counting only cysteines are also
included in brackets. The key histogram plots are shown in (B).
Whereas the KIM127 and MEM-48 epitopes are not expressed in
the transfectants of truncated variant L2-C573*, they are expressed
in the transfectants of L2-C575*.
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KIM127 and MEM-48 epitopes. To determine the N-terminal
boundary, we made a series of constructs, having di¡erent N-
termini, but with the stop codon at C575, and ligated them to
the C-terminal of the third and fourth Ig domain of rat CD4.
These constructs were transfected into COS-7 cells and ana-
lysed, ¢rst by intracellular staining as above, followed by im-
munoprecipitation of secreted fusion proteins after metabolic
labelling. Since the results are identical, only the immunopre-
cipitation results are shown. The supernatants were subjected
to immunoprecipitation with OX68 against the CD4 domains,
and the two mAbs KIM127 and MEM-48 (Fig. 3). OX68
precipitated the series of CD4-CRR fusion proteins, indicat-
ing that they are all secreted into the tissue culture medium.
CD4(E482^Q574) and CD4(E482^E614) were also precipi-
tated with KIM127 and MEM-48. However, if the two N-
terminal amino acids, namely E482 and C483, were removed
from CD4(E482^Q574) to give CD4(Q484^Q574), only weak
bands were detected in the immunoprecipitate with KIM127
and MEM-48. Since a full band was seen with OX68, the
ine⁄ciency of precipitation with KIM127 and MEM-48 sug-
gested the expression of defective or incomplete epitopes.
3.3. MEM-48 and KIM127 are two distinct mAbs
Although the mAbs MEM-48 and KIM127 give identical
results in this series of analyses, they can be distinguished in
the following experiment. Whereas the epitope of MEM-48 is
expressed at 4‡C on the LFA-1 of MOLT-4, that of KIM127
requires incubation at 37‡C in the presence of 5 mM MgCl2
and 1.5 mM EGTA (Fig. 4). This is in agreement with pre-
vious reports that the expression of the KIM127 epitope is
temperature-sensitive and can be activated with the mAb
KIM185 [23,24].
4. Discussion
Although it is documented that CRR of the integrin L sub-
units contains three or four repeating elements, the unit ele-
ment remains unde¢ned. In this study, we employed the strat-
egy of monitoring the expression of the epitopes of two mAbs
in segments of the CRR. A series of truncated L2 subunits
were constructed. The epitopes recognised by the mAbs
KIM127 and MEM-48 were expressed in the L2-C575* var-
iants and those that were longer, but not in the L2-C573* and
those that were shorter. Thus, a boundary has been deter-
mined to lie between the residues C573 and C575. A series
of rat CD4 fusion proteins were constructed with the di¡erent
lengths of L2 integrin segments ending at C575. We estab-
lished that the segment inclusive of E482 and Q574 of the
integrin L2 subunit is needed for the expression of the
KIM127 and MEM-48 epitopes. The epitopes are also ex-
pressed on the extended segment to end at E614, but their
expression is severely compromised if the segment starts at
Q484 instead of E482.
The minimum construct that expresses the epitopes of
KIM127 and MEM-48 is inclusive of residues E482 and
Q574. The disulphide bonds in this segment must be formed
correctly since both epitopes are lost upon reduction [15,16].
At the onset of the experiments, we argued that only when
complete units are included in the construct would they fold
correctly. By alignment analyses, each repeating unit should
contain eight cysteines [7,8]. The experimental result is there-
fore consistent with the preset conditions because the segment
E482^Q574 contains 16 cysteines, and therefore represents
two complete repeating units. Accordingly, three boundaries
are de¢ned at E482, E535, and Q574. Each of the two units
has the same arrangement of cysteines with the pattern: ‘xCö
CöCöCxCxxCxCöCx’, where ‘ö’ represent segments of
variable lengths from four to 14 residues, and ‘x’ represents
a single residue (it should be noted that the residue before the
¢rst cysteine and the residue after the last cysteine are always
included in the expression constructs). Another repeating unit
is found in the segment C-terminal to Q574, i.e. Q574^E614,
which has the eight cysteines arranged in an identical pattern.
We have previously determined the C-terminal residue of the
mid-region of the L2 subunit at Q444 [12]. The segment C455^
E482 is therefore bound by the mid-region at the N-terminal
side, and the cysteine repeating unit E482^E535 on the
C-terminal side. Eight cysteines are also found in this segment
and they are arranged in a pattern similar, but not identical,
to the other three repeating units. It is nonetheless convenient,
at this point, to refer to it as cysteine-rich region repeat 1
Fig. 3. The expression of CD4-CRR fusion proteins. COS-7 trans-
fectants were metabolically labelled with [35S]Met/Cys. Tissue cul-
ture supernatants were subjected to immunoprecipitation with OX68
(against rat CD4), and KIM127 and MEM-48 (against the CRR of
the L2 integrin subunit).
Fig. 4. The distinction between KIM127 and MEM-48. MOLT-4
cells were stained with the two mAbs in 10 mM HEPES, 150 mM
NaCl, and 0.2% (w/v) bovine serum albumin, pH 7.5, at 4‡C or at
37‡C, supplemented with 5 mM MgCl2 and 1.5 mM EGTA. The
epitope of KIM127 is not expressed at 4‡C. The expression of
LFA-1 is shown with the mAb MHM24 [19]. The background is
obtained with the mAb KB43 against the KXL2 integrin [20].
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(CRR1) spanning the region C445^E482. Thus, CRR2 will
span the region E482^E535, CRR3 E535^Q574, and CRR4
Q574^E614 (see Fig. 1).
The CRR repeating elements, before being de¢ned in this
work, have been assumed to be epidermal growth factor
(EGF)-like [1]. Indeed, a protein TIED has been described
to have ten integrin eGF-like domains with no other features
[25]. The boundaries of each repeat was o¡set by one cysteine
as those assigned here, i.e. each repeat would start with the
second cysteine and end with the ¢rst cysteine in the subse-
quent repeat. Curiously, the ¢rst cysteine in the entire se-
quence was ignored, and the ¢nal repeat has only seven cys-
teines. Thus, if the 10 units were assigned starting with the N-
terminal of the protein, such that each unit would have eight
cysteines, the pattern of cysteines in all 10 units would be
identical to those in CRR2, CRR3 and CRR4.
Although the cysteine residues are highly conserved in the
integrin L subunits, the conservation is not absolute. Two
cysteines in the core of the CRR are absent in the human
L4 and L8 subunits. They are equivalent to C536 and C559
of the human L2 subunit (see Fig. 1). It was proposed that
when a pair of cysteines are missing in homologous proteins,
they are likely, when present, to form a disulphide bond [26].
When applied to the CRR of the integrin L4 and L8 subunits,
both missing cysteines would be found in CRR3 according to
the proposed assignment herein. Thus, CRR3 of the integrin
L4 and L8 subunits would remain as self-contained structures,
each having six cysteines engaged in three disulphide bonds.
Pursuing the same argument, the two cysteine residues, when
present in an integrin subunit such as L2, should engage in a
disulphide bond. The conjecture will require future experi-
ments for veri¢cation.
The epitopes of the mAbs KIM127 and MEM-48 are not
identical (Fig. 4). Using human^mouse chimeras of the L2
integrin subunit, the species-speci¢c residues contributing to
the KIM127 epitope have been identi¢ed to G526, L528 and
Y530 in CRR2, and those to MEM-48 to L556, F558, and
H565 in CRR3 [12]. However, the epitope of KIM127 is not
expressed in the L2 truncated protein with a complete CRR2
(L2-C536*), a complete CRR3 (L2-C575*) is also required
(Fig. 2). Conversely, the epitope of MEM-48 is not expressed
in the CD4 fusion protein containing CRR3 only (E535^
Q574), the inclusion of a complete CRR2 (E482^E535) is
also required. Taken together, these results suggest that either
(1) residues common to both human and mouse in CRR3 also
contribute to the expression of the full epitope of KIM127,
and those in CRR2 to the expression of MEM-48 or (2) the
two CRR repeats require each other to fold correctly for the
expression of the two mAb epitopes. These alternatives cannot
be distinguished at present.
In conclusion, we have determined the boundaries of the
CRR repeats in the integrin L2 subunit, and shown that the
double repeats of CRR2^CRR3 can be expressed as CD4
fusion proteins independent of other integrin structures.
This ¢nding is likely to be applicable to other integrin L sub-
units, and will facilitate the design of future experiments in the
analyses of the structure of the CRR repeating units.
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